Joseph Palumbo
Chief Tech/Sci/R&D Officer at BIOVIE INC.
Net worth: 3 633 $ as of 2024-04-29
Joseph Palumbo active positions
Companies | Position | Start | End |
---|---|---|---|
BIOVIE INC. | Chief Tech/Sci/R&D Officer | 2021-10-31 | - |
HYDREIGHT TECHNOLOGIES INC. | Director/Board Member | 2022-11-24 | - |
Career history of Joseph Palumbo
Former positions of Joseph Palumbo
Companies | Position | Start | End |
---|---|---|---|
ZYNERBA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-06-30 | 2021-09-30 |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - | - |
Training of Joseph Palumbo
University of Pennsylvania Graduate School of Education | Undergraduate Degree |
George Washington University School of Medicine & Health | Doctorate Degree |
Statistics
International
United States | 7 |
Japan | 2 |
Operational
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
BIOVIE INC. | Health Technology |
HYDREIGHT TECHNOLOGIES INC. | Retail Trade |
Private companies | 1 |
---|---|
Mitsubishi Tanabe Pharma Corp.
Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
- Stock Market
- Insiders
- Joseph Palumbo
- Experience